News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Continue Reading Previous Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical UpdateNext Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™ Related Stories News Qoder Introduces Time-of-Day Credits Pricing for Qwen3.7-Max and Qwen3.7-Plus News LexisNexis Risk Solutions and Promon Align to Strengthen Mobile Fraud Prevention News Global-e Closes on Acquisition of Passport, a US-based e-Commerce Logistics and Solutions Company News Introducing HeyAdmin.ai – an Enterprise-grade Agentic AI Platform News G6 Hospitality Launches AI-Powered Video Tours to Elevate Guest Booking Experience News ThoughtSpot Named a Leader in the 2026 Gartner® Magic Quadrant™ for Analytics and BI Platforms
